Aoxing Pharma Revenue, Profits - AOXG Quarterly Income Statement

Add to My Stocks
$0.03 $0 (0%) AOXG stock closing price Sep 20, 2018 (Closing)

Looking at financial statements, along with the Aoxing Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $5.7M for 2017 Q3 impacts the AOXG stock. Investors typically check year over year or quarter over quarter revenue growth. The Aoxing Pharma profit and loss statement for 2017 Q3 shows a net profit of $-. Profits for last year was $-0.04M. Apart from this an investor should also check Aoxing Pharma assets and Aoxing Pharma free cash flow.

View and download details of revenue and profits for Aoxing Pharma for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jul - Jun2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Aoxing Pharma Revenues or Net Sales
5.7M8.01M7.56M8.83M6.56M8.2M
Cost Of Goods Sold (COGS)1.28M1.71M1.51M2.67M1.63M1.72M
Aoxing Pharma Gross Profit
4.42M6.29M6.05M6.18M4.93M6.46M
Research & Development Expense---1.97M-0.03M-
Selling General & Admin Expense3.34M5.86M3.85M5.92M3.32M2.1M
Income Before Depreciation Depletion Amortization--1.82M-1.71M1.64M3.53M
Depreciation Depletion Amortization------
Non Operating Income----0.03M-0.1M-
Interest Expense------
Aoxing Pharma Pretax Income
--0.38M1.04M-2.81M-2.59M
Provision for Income Taxes--0.35M--0.84M--
MinorityInterest----0.05M--
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations--0.04M--1.9M-2.07M
Extraordinary Items & Discontinued Operations------
Aoxing Pharma Profit/ Loss (Net Income)
--0.04M--1.9M-2.07M
Average Shares used to compute Diluted EPS76.21M76.21M-73.7M75.75M73.18M
Average Shares used to compute Basic EPS76.21M76.21M-73.7M75.67M73.1M
Income Before Nonrecurring Items--0.04M--1.9M-2.07M
Income from Nonrecurring Items------
Aoxing Pharma Earnings Per Share Basic Net
0.000.00--0.020.010.03
Aoxing Pharma Earnings Per Share Diluted Net
0.000.00--0.020.010.03
EPS Diluted Before Nonrecurring Items0.000.00--0.020.010.03
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Aoxing Pharma stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Aoxing Pharma revenue chart, implies that the company is growing. It has not been the case with Aoxing Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like Aoxing Pharma try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the AOXG income statement, one can check the Aoxing Pharma historical stock prices to check how the price has moved with time.

Aoxing Pharma Income Statement - Key Financial Ratios